You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) MICROCRYSTALLINE CELLULOSE 112


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing MICROCRYSTALLINE CELLULOSE 112 excipient

MICROCRYSTALLINE CELLULOSE 112 Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Microcrystalline Cellulose 112

Introduction to Microcrystalline Cellulose 112

Microcrystalline cellulose (MCC) 112 is a specialized excipient widely used in the pharmaceutical industry, particularly for formulations containing moisture-sensitive active ingredients. Its unique properties make it an essential component in the production of tablets, capsules, and granules.

Key Characteristics of MCC 112

MCC 112 is distinguished by its low residual moisture content, typically less than 1.5%, and a water activity below 0.18. These characteristics are crucial for formulations involving moisture-sensitive ingredients such as certain active pharmaceutical ingredients, vitamins, minerals, and probiotics. The low water activity reduces the degradation risk of these sensitive components and inhibits the action of microorganisms in probiotics[1][5].

Market Size and Growth

The global microcrystalline cellulose market, which includes MCC 112, has been experiencing significant growth. As of 2024, the market was valued at approximately USD 1.38 billion and is projected to reach USD 2.46 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.24%[3].

Industry Drivers

Pharmaceutical Sector

The pharmaceutical industry is a major driver of the MCC market. The increasing global spending on healthcare and the rising prevalence of chronic diseases are fueling the demand for MCC. The sector's need for high-quality excipients in drug formulations, particularly those enhancing tablet compressibility, stability, and bioavailability, is a key factor. Innovative drug development, including personalized medicine and advanced drug delivery systems, further boosts the demand for MCC[3].

Food and Cosmetics Industries

In addition to pharmaceuticals, MCC is gaining traction in the food and cosmetics industries. It is used as a fat replacer and stabilizer in low-calorie and gluten-free products, contributing to its market growth. The rising preference for processed and health-oriented foods, especially in regions like North America and the Asia Pacific, is also driving demand[3].

Regional Market Dynamics

North America

North America is a dominant region in the MCC market, largely due to its robust pharmaceutical sector. The consistent increase in new drug approvals by the U.S. Food and Drug Administration (FDA) highlights the expanding pharmaceutical landscape, directly driving the demand for MCC. The region's preference for processed foods also contributes to the sustained growth of the MCC market[3].

Europe

Europe, particularly Germany, is another significant market for MCC. The region's demand is expected to increase rapidly due to the rise in usage across various applications. Technological advancements and the strong presence of pharmaceutical companies in Europe are expected to propel the market forward[4].

Asia Pacific

The Asia Pacific region is poised for substantial growth due to its increasing population and rising disposable incomes. The United Nations projects that Asia’s population will rise to 5.2 billion by 2050, creating a significant demand for food and pharmaceutical products where MCC is widely used. This demographic shift, combined with the growing preference for convenient and health-oriented products, will drive market expansion in the region[3].

Applications and Usage

MCC 112 is versatile and can be used in various pharmaceutical formulations:

Direct Compression and Dry Granulation

MCC 112 is recommended for both direct compression and dry granulation processes in the manufacturing of tablets, capsules, and granules. Its excellent binding, disintegration, and flow properties make it an ideal excipient for these processes[1][5].

Formulations with Moisture-Sensitive Ingredients

The low moisture content and water activity of MCC 112 make it particularly suitable for formulations containing moisture-sensitive active ingredients. This reduces the risk of degradation and ensures the stability of the final product[1].

Compliance and Quality Standards

MCC 112 complies with the latest editions of major pharmacopeias, including USP/NF, Ph.Eur., JP, and IP. This ensures that the product meets stringent quality standards, which is crucial for its use in pharmaceutical formulations[1].

Financial Trajectory

The financial trajectory of the MCC market, including MCC 112, is promising:

  • Market Valuation: The market was valued at USD 1.38 billion in 2024 and is expected to reach USD 2.46 billion by 2031[3].
  • CAGR: The market is growing at a CAGR of 8.24% during this period[3].
  • Regional Growth: North America and Europe are currently leading the market, with the Asia Pacific region expected to show significant growth in the future[3][4].

Key Takeaways

  • Growing Demand: The demand for MCC 112 is driven by the expanding pharmaceutical industry, innovative drug development, and increasing use in food and cosmetics.
  • Regional Dominance: North America and Europe are current leaders, with the Asia Pacific region poised for significant growth.
  • Compliance: MCC 112 meets stringent quality standards, ensuring its suitability for pharmaceutical formulations.
  • Versatile Applications: It is used in direct compression, dry granulation, and formulations with moisture-sensitive ingredients.

FAQs

What are the key characteristics of MCC 112?

MCC 112 is characterized by its low residual moisture content (less than 1.5%) and low water activity (below 0.18), making it ideal for formulations with moisture-sensitive ingredients.

Which industries drive the demand for MCC 112?

The pharmaceutical, food, and cosmetics industries are the primary drivers of the demand for MCC 112.

What is the projected market size of the MCC market by 2031?

The global MCC market is projected to reach approximately USD 2.46 billion by 2031.

Which regions are leading the MCC market?

North America and Europe are currently the leading regions, with the Asia Pacific region expected to show significant growth in the future.

What are the compliance standards for MCC 112?

MCC 112 complies with the latest editions of USP/NF, Ph.Eur., JP, and IP pharmacopeias.

Sources

  1. Alsiano: MCC 112 for moisture sensitive active ingredients.
  2. Fortachem: Microcrystalline Cellulose pH112, Low Moisture Avicel 112.
  3. Verified Market Research: In-Depth Industry Outlook: Microcrystalline Cellulose Market Size – 2024-2031.
  4. Transparency Market Research: Microcrystalline Cellulose Market Size, Statistics Report, 2031.
  5. Roquette: MICROCEL® 112 SD Microcrystalline Cellulose.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.